Influenza vaccination coverage rates insufficient across EU Member States
None of the European Union (EU) Member States could demonstrate that they reach the EU target of 75% influenza vaccination coverage for vulnerable groups, according to a new report from the European Centre for Disease Prevention and Control (ECDC).
Expert panel reviews neuraminidase inhibitors for the prevention and treatment of influenza
An ECDC expert opinion concludes that there is clear evidence supporting the use of neuraminidase inhibitors in the treatment and prevention of influenza. Moreover, the current recommendations in European countries on the use of the neuraminidase inhibitors oseltamivir and zanamivir are appropriate and should be applied by prescribing physicians.
World Tuberculosis Day - 24 March 2016
Marked each year on 24 March, World Tuberculosis Day gives the occasion to raise awareness about tuberculosis (TB) and to advocate more efforts to eliminate it. ECDC has launched the latest surveillance data and materials on interventions addressing vulnerable groups.
New and updated evaluations of neuraminidase inhibitors for preventing and treating influenza published
This evaluated patients admitted to hospital with laboratory-confirmed or clinically diagnosed influenza A H1N1pdm09 virus infection.
ECDC Director at European Tuberculosis Networks meeting: “We need to remain vigilant”
Three European networks in TB surveillance, laboratory and prevention and control are coming together to discuss tuberculosis elimination. ECDC Director Marc Sprenger says TB in Europe needs to be taken seriously.
How effective were neuraminidase inhibitors during the 2009 pandemic?Archived
This systematic review and meta-analysis of observational data from an established group of specialists assessed treatment outcomes for all three neuraminidase inhibitors (NAIs); oseltamivir, zanamivir and peramivir given to hospitalised patients with influenza A(H1N1)pdm09 during the 2009 pandemic.
TB control – a “common responsibility”, says ECDC Director Marc SprengerArchived
While many European countries are progressing towards TB elimination, the target of less than 1 TB case/ 1,000,000 population is still far from being achieved everywhere. This was one of the messages presented today by ECDC Director Marc Sprenger during the joint session with WHO "Towards elimination of tuberculosis" at the European Respiratory Society annual congress.